tert-Butyl (3-methylbenzyl)carbamate

Catalog No.: 
ACUJAA285
CAS No.: 
179876-20-1
Molecular Formula: 
C13H19NO2
Molecular Weight: 
221.30
tert-Butyl (3-methylbenzyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$81.00InquiryInquiry
5g95%$168.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-methylbenzyl)carbamate
IUPAC Nametert-Butyl (3-methylbenzyl)carbamate
MDL No.MFCD21106051
Molecular FormulaC13H19NO2
Molecular Weight221.30
SMILESCC1=CC=CC(CNC(OC(C)(C)C)=O)=C1
InChI KeyBWIWNCKYTQDJRE-UHFFFAOYSA-N
SynonymBWIWNCKYTQDJRE-UHFFFAOYSA-N;Carbamic acid, N-[(3-methylphenyl)methyl]-, 1,1-dimethylethyl ester;1,1-Dimethylethyl N-[(3-methylphenyl)methyl]carbamate
CAS No.179876-20-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACUJAA285 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNFXV602 route compound structure diagram
    ACNFXV602171663-13-1In Stock
  4. Then
  5. ACUJAA285 route product structure diagram
    ACUJAA285179876-20-1
Inquiry

2. ACUJAA285 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUJAA285 route product structure diagram
    ACUJAA285179876-20-1
Inquiry

3. ACUJAA285 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUJAA285 route product structure diagram
    ACUJAA285179876-20-1
Inquiry

Comments (0)